Rothamsted Research Applies for New Trials of GM CamelinaFebruary 13, 2019
The application is for a five-year project, ending in 2023, with plants being sown in April, and harvested in September and follows previous GM Camelina trials carried out in 2018 across two sites in Hertfordshire and Suffolk.
The first part of the trial will determine performance in the field, and the seed oil yield, of transgenic Camelina plants that have been engineered to accumulate polyunsaturated fatty acids in their seeds. The second strand of work will look at the performance of Camelina plants whose metabolism has been altered to increase seed oil content. The final part will investigate the performance of Camelina plants engineered to contain less sinapine in their seeds. Sinapine is a bitter-tasting chemical that makes the protein-rich seed meal less palatable as an animal feed.
For more details, read the news article in Rothamsted Research.
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- A Comprehensive Review of the Environmental Safety of Bt Crops Now Published
- New Chocolate has Its Own Pro-GMO Label to Promote GMO Farming
- NASA: Tree Planting and Agri in China and India Make Earth Greener
- Experts Call for Urgent Political Support for Agri-biotech in the Philippines
- Genes that Resist White Rust Pathogen Found
- Study Finds Attitudes of the Youth toward GM Food Affected by Family Members
- Rothamsted Research Applies for New Trials of GM Camelina
- COGEM: No Risk in Import and Processing of GM Maize Bt11
- Scientists Report First Genetic Transformation of Einkorn
- Haplotype Analysis of Rice Genes Helps Development of Tailor-made Rice with Improved Genetic Gains
- GMOs Not the Cause of Monarch Butterfly Decline, Study
Plant Breeding Innovations
- CRISPR-Cas9 Used for Targeted Disruption of FAD2–2 Microsomal Omega-6 Desaturase in Soybean
- Improved CRISPR System with Power on Switch for Gene Editing
Beyond Crop Biotech
- NRGene and Kayagene Introduce the First Fully-Phased Cannabis Genome
- International Conference on Industrial Crops
Subscribe to CBU: